From Pricing To Tax Havens: AbbVie On The Hot Seat Again With US Congress
Executive Summary
Senate committee seeks details on company’s international tax practices as congress works to implement President Biden’s proposals on corporate tax reform.
You may also be interested in...
Experience Counts When Shaping Policy Strategies
Hayden Kennedy, AbbVie’s VP of global policy and US access strategies, and one of In Vivo’s 2021 Rising Leaders, shares her approach to tackling gender diversity and discusses how a background in government has helped shape her thinking in pharma.
US Patent Reform Legislation Threatened By Biden Support For Vaccine IP Waiver, Republicans Say
At hearing on Humira patent thicket, House Republicans express concern that Democrats’ support for transferring US intellectual property rights for COVID-19 vaccines to other countries is a bad sign for collaboration on legislation to reform patent abuses.
Biden Infrastructure Plan Offers Biopharma R&D Carrot, Tax Stick
Tens of billions would go to fund R&D, including Phase I and Phase II development of vaccines. But the plan would also crack down on inversions and offshoring.